On the Interplay of Telomeres, Nevi and the Risk of Melanoma

• Clara Bodelon,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Ruth M. Pfeiffer,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Valentina Bollati,

  Affiliations Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, Università di Milano, Milan, Italy, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  ⨯
• Julien Debbache,

  Affiliations Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America, Cell and Developmental Biology Division, Universität Zürich, Zürich, Switzerland

  ⨯
• Donato Calista,

  Affiliation Department of Dermatology, M. Bufalini Hospital, Cesena, Italy

  ⨯
• Paola Ghiorzo,

  Affiliations Department of Internal Medicine, University of Genoa, Genoa, Italy, Laboratory of Genetics of Rare Hereditary Cancers, IRCCS AOU San Martino-IST, Genoa, Italy

  ⨯
• Maria Concetta Fargnoli,

  Affiliation Department of Dermatology, University of L’Aquila, L’Aquila, Italy

  ⨯
• Giovanna Bianchi-Scarra,

  Affiliations Department of Internal Medicine, University of Genoa, Genoa, Italy, Laboratory of Genetics of Rare Hereditary Cancers, IRCCS AOU San Martino-IST, Genoa, Italy

  ⨯
• Ketty Peris,

  Affiliation Department of Dermatology, University of L’Aquila, L’Aquila, Italy

  ⨯
• Mirjam Hoxha,

  Affiliations Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, Università di Milano, Milan, Italy, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  ⨯
• Amy Hutchinson,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Laurie Burdette,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Laura Burke,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Shenying Fang,

  Affiliation Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Margaret A. Tucker,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Alisa M. Goldstein,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Jeffrey E. Lee,

  Affiliation Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Qingyi Wei,

  Affiliation Department of Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Sharon A. Savage,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Xiaohong R. Yang,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Christopher Amos,

  Affiliation Department of Community and Family Medicine, Center for Genomic Medicine, Dartmouth University, Lebanon, New Hampshire, United States of America

  ⨯
•  [ ... ],
• Maria Teresa Landi

  * E-mail: landim@mail.nih.gov

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]